相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities
Cirino Botta et al.
FRONTIERS IN ONCOLOGY (2014)
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
Syed H. Jafri et al.
BMC CANCER (2013)
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta et al.
CANCER BIOLOGY & THERAPY (2013)
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A. Morse et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients
Anita K. Gandhi et al.
PLOS ONE (2013)
Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
Jarrod Predina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2012)
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients
Cirino Botta et al.
JOURNAL OF IMMUNOTHERAPY (2012)
The regulation of the development and function of dendritic cell subsets by GM-CSF: More than a hematopoietic growth factor
Yifan Zhan et al.
MOLECULAR IMMUNOLOGY (2012)
Transcriptional Activation and Cell Cycle Block Are the Keys for 5-Fluorouracil Induced Up-Regulation of Human Thymidylate Synthase Expression
Alessio Ligabue et al.
PLOS ONE (2012)
Tumor infiltration by chemokine receptor 7 (CCR7)+ T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
Pierpaolo Correale et al.
ONCOIMMUNOLOGY (2012)
Autoimmunity associated with immunotherapy of cancer
Sally M. Amos et al.
BLOOD (2011)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Cancer vaccines inducing antibody production: more pros than cons
Erika Jensen-Jarolim et al.
EXPERT REVIEW OF VACCINES (2011)
Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience
Hakan Mellstedt et al.
LUNG CANCER (2011)
Response definition criteria for ELISPOT assays revisited
Z. Moodie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Cancer immunotherapy
Constantin N. Baxevanis et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
S. Mocellin et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Federica Sallusto et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial)
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2008)
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
P Correale et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine
P Correale et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
P Correale et al.
JOURNAL OF IMMUNOLOGY (2005)
Thymidylate synthase: A critical target in cancer therapy?
YM Rustum
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects
NC Santos et al.
BIOCHEMICAL PHARMACOLOGY (2003)
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects
G Francini et al.
JOURNAL OF IMMUNOLOGY (2002)
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase
P Correale et al.
JOURNAL OF CHEMOTHERAPY (2001)
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2: results from a phase Ib clinical trial
P Correale et al.
EUROPEAN JOURNAL OF CANCER (2001)
分享论文
